Published in Hepatitis Weekly, March 26th, 2001
The scientists, members of a research team at Kanazawa University in Japan, have used complementary DNA (cDNA) microarray technology to study genetic differences in tissue lesions of patients with chronic hepatitis B or C. Their research suggests differential expression of genes that control inflammatory factors influence the body's response to hepatitis B virus (HBV) or hepatitis C virus (HCV).
"We made cDNA microarrays consisting of 1080 human cDNAs and analyzed gene expression using labeled cDNAs...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.